• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by CM Life Sciences II Inc. (Amendment)

    9/24/21 4:58:16 PM ET
    $CMII
    Blank Checks
    Finance
    Get the next $CMII alert in real time by email
    SC 13G/A 1 somalogic_13ga1.htm SC 13G/A
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
     
    (Amendment No. 1)*
     
    SomaLogic, Inc.
    (Name of Issuer)
     
    Class A Common Stock, $0.0001 par value per share
    (Title of Class of Securities)
     
    83444K105
    (CUSIP Number)
     
    September 1, 2021
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    o Rule 13d-1(b)
    x Rule 13d-1(c)
    o Rule 13d-1(d)
       

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).  

     
     
    CUSIP No. 83444K105 13G Page 2 of 8

     

                 
    1.

    Names Of Reporting Persons

     

    GAGNON SECURITIES LLC

     

     
           
    2. check the appropriate box if a group (a) o
    (b) o

    3. sec use only    
           
    4.

    citizenship or place of organization

     

    DELAWARE LIMITED LIABILITY COMPANY

     

       
    number of
    shares
    beneficially
    owned by
    each
    reporting
    person with:
    5. sole voting power     0
    6. shared voting power     1,192,024
    7. sole dispositive power     0
    8. shared dispositive power     1,261,837
    9. aggregate amount beneficially owned by each reporting person   1,261,837
    10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) x
    11. percent of class represented by amount in row (9)  

    0.7%

    12. type of reporting person (See Instructions)     IA, BD

     

     
     
     
    CUSIP No. 83444K105 13G Page 3 of 8

     

                 
    1.

    Names Of Reporting Persons

     

    GAGNON ADVISORS, LLC

     

     
           
    2. check the appropriate box if a group (a) o
    (b) o

    3. sec use only    
           
    4.

    citizenship or place of organization

     

    DELAWARE LIMITED LIABILITY COMPANY

     

       
    number of
    shares
    beneficially
    owned by
    each
    reporting
    person with:
    5. sole voting power     0
    6. shared voting power     615,562
    7. sole dispositive power     0
    8. shared dispositive power    

    615,562

    9. aggregate amount beneficially owned by each reporting person  

    615,562

    10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) x
    11. percent of class represented by amount in row (9)  

    0.3%

    12. type of reporting person (See Instructions)     IA

     

     
     
     
    CUSIP No. 83444K105 13G Page 4 of 8

     

                 
    1.

    Names Of Reporting Persons

     

    NEIL GAGNON

     

     
           
    2. check the appropriate box if a group (a) o
    (b) o

    3. sec use only    
           
    4.

    citizenship or place of organization

     

    USA

     

       
    number of
    shares
    beneficially
    owned by
    each
    reporting
    person with:
    5. sole voting power    

    213,515

    6. shared voting power    

    1,922,845

    7. sole dispositive power    

    213,515

    8. shared dispositive power    

    2,001,330

    9. aggregate amount beneficially owned by each reporting person  

    2,214,845

    10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) x
    11. percent of class represented by amount in row (9)  

    1.2%

    12. type of reporting person (See Instructions)     IN

     

     
     
     
    CUSIP No. 83444K105 13G Page 5 of 8
    Item 1.  

     

    (a) Name of Issuer: SomaLogic, Inc.
         
    (b) Address of Issuer’s Principal

    2945 Wilderness Place

      Executive Offices:

    Boulder, Colorado 80301

     

    Item 2.

    (a) Name of Person Filing:

    Neil Gagnon has sole voting and dispositive power over 213,515 shares of the Issuer’s Class A Common Stock, par value $0.0001 per share (the “common stock”). In addition, Mr. Gagnon has shared voting power over 1,922,845 shares of common stock and shared dispositive power over 2,001,330 shares of common stock.

     

    Mr. Gagnon is the managing member and principal owner of Gagnon Securities LLC (“GS”), an investment adviser registered with the Securities and Exchange Commission (“SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), and a registered broker-dealer, in its role as investment manager to several customer accounts, foundations, partnerships and trusts (collectively, the “Accounts”) to which it furnishes investment advice. GS and Mr. Gagnon may be deemed to share voting power with respect to 1,192,024 shares of common stock held in the Accounts and dispositive power with respect to 1,261,837 shares of common stock held in the Accounts. GS and Mr. Gagnon expressly disclaim beneficial ownership of all securities held in the Accounts.

     

    Mr. Gagnon is also the Chief Executive Officer of Gagnon Advisors, LLC (“Gagnon Advisors”), an investment adviser registered with the SEC under the Advisers Act. Mr. Gagnon and Gagnon Advisors, in its role as investment manager to Gagnon Investment Associates, LLC (“GIA”), a private investment fund, may be deemed to share voting and dispositive power with respect to the 615,562 shares of common stock held by GIA. Gagnon Advisors and Mr. Gagnon expressly disclaim beneficial ownership of all securities held by GIA.

     

    (b) Address of Principal Business Office: 1370 Ave. of the Americas, 24th Floor
      or, if none, Residence New York, NY 10019

     

    (c) Citizenship:

    USA

         
    (d) Title of Class of Securities:

    Class A Common Stock, par value $0.0001 per share

         
    (e) CUSIP Number: 83444K105

     

     
     
     
    CUSIP No. 83444K105 13G Page 6 of 8
       
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

     

    (a)  o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
         
    (b)  o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
         
    (c)  o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
         
    (d)  o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
         
    (e)  o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
         
    (f)  o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
         
    (g)  o A parent holding company or control person in accordance with § 13d-1(b)(1)(ii)(G);
         
    (h)  o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
         
    (i)  o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15U.S.C. 80a-3);
         
    (j)  o A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
         
    (k)  o Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

     

     
     
     
    CUSIP No. 83444K105 13G Page 7 of 8
    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a) Amount beneficially owned:

    Gagnon Securities LLC

    1,261,837

         

    Gagnon Advisors, LLC

    615,562

         

    Neil Gagnon

    2,214,845

           
      (b) Percent of class:

    Gagnon Securities LLC

    0.7%

         

    Gagnon Advisors, LLC

    0.3%

         

    Neil Gagnon

    1.2%

           
         

    Calculation of percentage of beneficial ownership is based on 181,163,363 shares of common stock outstanding as of September 1, 2021, as reported by the Issuer on its Form 8-K filed on September 8, 2021.

           
      (c) Number of shares as to which the person has:

     

      (i) Sole power to vote or to direct the vote:

    Gagnon Securities LLC

    0

         

    Gagnon Advisors, LLC

    0
         

    Neil Gagnon

    213,515

           
      (ii) Shared power to vote or to direct the vote:

    Gagnon Securities LLC

    1,192,024

         

    Gagnon Advisors, LLC

    615,562

         

    Neil Gagnon

    1,922,845

           
      (iii) Sole power to dispose or to direct the disposition of:

    Gagnon Securities LLC

    0
         

    Gagnon Advisors, LLC

    0
         

    Neil Gagnon

    213,515

           
      (iv) Shared power to dispose or to direct the disposition of:

    Gagnon Securities LLC

    1,261,837

         

    Gagnon Advisors, LLC

    615,562

         

    Neil Gagnon

    2,011,330

    Item 5. Ownership of Five Percent or Less of a Class.
       

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    The Accounts described above in Item 2 have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities held in their respective accounts. To the knowledge of the Reporting Persons, the interest in any such account does not exceed 5% of the class of securities. Except to the extent described herein, each Reporting Person disclaims beneficial ownership of all such securities.

     

    Items 7 – 9. Not Applicable.

     

     
     
     
    CUSIP No. 83444K105 13G Page 8 of 8
       
    Item 10. Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 230.14a-11.

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: September 24, 2021

       
      NEIL GAGNON
       
     

    /s/ Neil Gagnon

       
     

    GAGNON SECURITIES LLC

       
     

    /s/ Neil Gagnon

      Name:  Neil Gagnon 
     

    Title:    Managing Member

       
     

    GAGNON ADVISORS, LLC

       
     

    /s/ Neil Gagnon

      Name:  Neil Gagnon 
     

    Title:    Chief Executive Officer

       
     
     
    Get the next $CMII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Columbus Circle 2 Sponsor Corp Llc bought $2,650,000 worth of Class A ordinary shares (265,000 units at $10.00) (SEC Form 4)

    4 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/17/26 8:42:53 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Alsina Gonzalez Alberto

    3 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/10/26 9:48:19 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Murphy Matthew Joseph

    3 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/10/26 9:47:48 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    SEC Filings

    View All

    SEC Form 10-K filed by Columbus Circle Capital Corp II

    10-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    3/30/26 5:29:42 PM ET
    $CMII
    Blank Checks
    Finance

    CM Life Sciences II Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    2/26/26 4:55:40 PM ET
    $CMII
    Blank Checks
    Finance

    CM Life Sciences II Inc. filed SEC Form 8-K: Leadership Update

    8-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    2/19/26 4:32:06 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Columbus Circle 2 Sponsor Corp Llc bought $2,650,000 worth of Class A ordinary shares (265,000 units at $10.00) (SEC Form 4)

    4 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/17/26 8:42:53 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CM Life Sciences II Inc.

    SC 13G - SomaLogic, Inc. (0001837412) (Subject)

    10/8/21 4:07:06 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by CM Life Sciences II Inc. (Amendment)

    SC 13G/A - SomaLogic, Inc. (0001837412) (Subject)

    9/24/21 4:58:16 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form SC 13D filed by CM Life Sciences II Inc.

    SC 13D - SomaLogic, Inc. (0001837412) (Subject)

    9/15/21 6:20:38 AM ET
    $CMII
    Blank Checks
    Finance